Tag:
Indocin
Latest Headlines
Latest Headlines
FTC's antitrust loss may set pharma precedent
One drugmaker prevails in an antitrust case, and all drugmakers could benefit. Such is the story with the Federal Trade Commission's recent failure to smack down Ovation Pharmaceuticals (now
Ovation's drug price hike leads to lawsuit
Ovation Pharmaceuticals may be in hot water. The company, which dedicates itself to drugs for rare medical conditions, purchased the rights to Merck's Indocin in 2005, bought a rival drug in 2006 and
